Mattick, L. J., Bea, J. W., Hovey, K. M., Wactawski-Wende, J., Cauley, J. A., Crandall, C. J., . . . Ochs-Balcom, H. M. (2023). Follicle-stimulating hormone is associated with low bone mass in postmenopausal women. Osteoporosis International: With other metabolic bone diseases, 34(4), 693-701. https://doi.org/10.1007/s00198-023-06676-z
Chicago Style (17th ed.) CitationMattick, Lindsey J., Jennifer W. Bea, Kathy M. Hovey, Jean Wactawski-Wende, Jane A. Cauley, Carolyn J. Crandall, Lili Tian, and Heather M. Ochs-Balcom. "Follicle-stimulating Hormone Is Associated with Low Bone Mass in Postmenopausal Women." Osteoporosis International: With Other Metabolic Bone Diseases 34, no. 4 (2023): 693-701. https://doi.org/10.1007/s00198-023-06676-z.
MLA (9th ed.) CitationMattick, Lindsey J., et al. "Follicle-stimulating Hormone Is Associated with Low Bone Mass in Postmenopausal Women." Osteoporosis International: With Other Metabolic Bone Diseases, vol. 34, no. 4, 2023, pp. 693-701, https://doi.org/10.1007/s00198-023-06676-z.